Return to Article Details
OPTIMIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH STABLE CORONARY HEART DISEASE COMBINED WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN STAGE OF STEATOHEPATITIS
Download
Download PDF